Global Genetic Testing Market Size, Strategies and Forecasts Report 2016-2020 - Types, Examples and Discussion

DUBLIN, December 11, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/7frp77/the_global) has announced the addition of the "The Global Genetic Testing Market Size, Strategies and Forecasts 2016 to 2020" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

The report forecasts the market size out to 2020. The report includes detailed breakouts for 14 countries and 5 regions.

The role of genetics in health and disease is just now being understood. This new knowledge, combined with lower pricing is driving the Genetic Testing industry to record growth. New drugs may only work for people with a certain genetic makeup, and this too is driving the Genetic Testing Industry. The traditional genetic testing market is growing in volume and growing in the breadth of tests creating new life for the industry.

Predictive Diagnostics? Pharmacogenomic Testing? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five.

Key Topics Covered:

1. Introduction and Market Definition

2. Market Overview

3. Market Trends

4. Genetic Testing Recent Developments

5. Country Market Sizes - North America

6. Country Markets - Europe

7. Country Markets - Asia Pacific

8. Country Markets - Latin America, Africa & The Middle East

9. Global Market Summary

10. The Future of Genetic Testing

Companies Mentioned

- 14M Genomics

- 23andMe

- Abbott Laboratories

- Abcam

- Accelerate Diagnostics

- ACT Genomics

- Adaptive Biotechnologies

- Admera Health

- Aegis Sciences

- Agena Bioscience

- Agendia

- Agilent/Dako

- AltheaDx

- Amarantus

- Ariosa Diagnostics

- Atossa Genetics

- Baylor College of Medicin

- Becton, Dickinson & Co.

- Biofortuna

- BioMerieux

- BioReference Laboratories, Inc.

- Bloom Burton

- Canon US Life Sciences

- Caprion

- CardioDx

- Cepheid

- Cigna

- Claritas Genomics

- Cypher Genomics

- Cytogenetics

- DiaCarta

- DioGenix

- Enzo Biochem

- Epic Sciences

- Firefly

- Foundation Medicine

- Genentech

- GenMark

- GenomeDx Biosciences

- Genomic Health

- Glyconics

- Good Start Genetics

- Google

- Great Basin Scientific

- Grifols

- Hologic

- HTG Molecular Diagnostics

- Illumina

- Interleukin Genetics

- Invitae

- Life Letters

- Lifecode

- MDx Firm Diagnovus

- MDxHealth

- Merck Serono

- Metamark

- Miraca Holdings

- MolecularMD

- Multiplicom

- Myriad Genetics

- NanoString Technologies

- Novacyt

- Nuclea Bio

- Precipio Diagnostics

- Premaitha Health plc

- Protagen

- Qiagen

- QuantRx® Biomedical

- Quidel

- Roche Molecular Diagnostics

- Rosetta

- Sequenom

- Sequenta

- Sera

- Siemens Healthcare

- Signal Genetics LLC

- Sysmex Inostics

- T2 Biosystems

- Thermo Fisher

- Transgenomic

- Trinity Biotech

For more information visit http://www.researchandmarkets.com/research/7frp77/the_global

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net